<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03180918</url>
  </required_header>
  <id_info>
    <org_study_id>PB_2016-01378</org_study_id>
    <nct_id>NCT03180918</nct_id>
  </id_info>
  <brief_title>Male Fertility Preservation Using Cryopreservation of Testicular Tissue Before Highly Gonadotoxic Cancer Treatment</brief_title>
  <official_title>Male Fertility Preservation Using Cryopreservation of Testicular Tissue Before Highly Gonadotoxic Cancer Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gumy-Pause Fabienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Geneva</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background:

      Due to the remarkable improvement in treatments these last decades, long term survival can be
      expected in more than 80% of childhood cancer patients. Unfortunately, cancer treatments can
      be harmful to the gonads and can affect reproductive and endocrine functions. While loss of
      fertility is a major concern for most patients, sperm cryopreservation should be offered to
      all pubertal male patients. For prepubertal boys, only the experimental option of testicular
      biopsy in order to cryopreserve testicular stem cells can be proposed.

      Primary aims

      - To cryopreserve testicular tissue of prepubertal patient receiving highly gonadotoxic
      oncological treatment.

      Secondary aims

        -  To cryopreserve testicular tissue after failure of sperm cryopreservation in pubertal
           patient with high risk of infertility

        -  To create a database in order to record clinical and biological follow-up data

        -  To create a research biobank for future research projects

      Multicentric study: HUG, CHUV, UKBB
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2015</start_date>
  <completion_date type="Anticipated">January 2100</completion_date>
  <primary_completion_date type="Anticipated">January 2100</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of pediatric cancer patient who will undergo testicular tissue cryopreservation for fertility preservation</measure>
    <time_frame>0-20 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of complications related to the testicular biopsy (safety)</measure>
    <time_frame>0-20 years</time_frame>
    <description>The safety will be assessed by recording the number of complications of the procedure (e.g. bleeding, infection, testicular atrophy)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of biochemical markers</measure>
    <time_frame>0-20 years</time_frame>
    <description>Comparison of biochemical markers (e.g., FSH; LH, AMH; Inhibin B, SHBG and testosterone) between patients who undergo testicular biopsy and controls</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Childhood Cancer</condition>
  <condition>Fertility Disorders</condition>
  <arm_group>
    <arm_group_label>testicular tissue cryopreservation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>testicular tissue biopsy</intervention_name>
    <description>testicular tissue biopsy during general anesthesia</description>
    <arm_group_label>testicular tissue cryopreservation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Prepubertal patients aged 3 months and older

          -  Peri and pubertal patients after failure of sperm cryopreservation

          -  Patients presenting high risk of infertility because of gonadotoxic treatments (i.e
             high dose of alkylating agents, testicular irradiation, total body irradiation).

          -  Multidisciplinary team consensus in favour of proposition to cryopreserve testicular
             tissue

        Exclusion Criteria:

          -  Patients under the age of 3 months

          -  Refusal of the patient and/or his parents

          -  Treatments that are not highly gonadotoxic
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>3 Months</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Fabienne Gumy-Pause, Dr</last_name>
    <email>fabienne.gumypause@hcuge.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>UKBB</name>
      <address>
        <city>Basel</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tamara Diesch-Furlanetto, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Geneva University Hospitals</name>
      <address>
        <city>Geneva</city>
        <zip>1211</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabienne Gumy-Pause, Dr</last_name>
      <email>fabienne.gumypause@hcuge.ch</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHUV</name>
      <address>
        <city>Lausanne</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maja Beck Popovic, Dr</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 31, 2017</study_first_submitted>
  <study_first_submitted_qc>June 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 8, 2017</study_first_posted>
  <last_update_submitted>June 7, 2017</last_update_submitted>
  <last_update_submitted_qc>June 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Geneva</investigator_affiliation>
    <investigator_full_name>Gumy-Pause Fabienne</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

